NR4A1 and neoplasm: These factors include the hormone receptor status, the intrinsic molecular subtypes of breast cancer [11–13], or the percentage of stromal tumor-infiltrating lymphocytes (TILs) [13–15], all of which have been associated with treatment response and survival.